NEW YORK (GenomeWeb News) – Kinetic Concepts has appointed TLV Kumar to be president of the company’s Europe, Middle East, and Africa operations and to be a member of KCI’s executive committee.
Kumar, who will report to President and CEO Catherine Burzik, will be based in the company’s office in Amstelveen, Netherlands. Kumar formerly was president of the Asia-Pacific region at Applied Biosystems and was COO of Asia-Pacific operations at Philips Medical Systems.
Gene Express has appointed David Sidransky and Michael Liebman to its scientific advisory board. Sidransky is director of the Head and Neck Cancer Research Division at Johns Hopkins University’s School of Medicine and a professor at JHU’s medical school. He also has been a director at ImClone and he has served on scientific advisory boards at MedImmune, Amgen, and Veridex, and he is vice chairman at Alfacell.
Liebman is managing director of Strategic Medicine and is a senior institute fellow at the Windber Research Institute. He was director of computational biology and biomedical informatics at the Abramson Family Cancer Research Institute at the University of Pennsylvania. Liebman also was global head of computational genomics at Roche Pharmaceuticals, director of bioinformatics and pharmacogenomics at Wyeth Pharmaceuticals, and he was director of genomics for Vysis.
Proxeon has added some new faces to its North American and European businesses. John Lindsay will step into the VP of sales and marketing spot in North America, where he will work with VP of North American Business Development John Chakel, formerly of Agilent Technologies.
In the European business, Derek Potter has become director of sales and marketing, Alistair Sterling will be responsible for technical support, and Christian Ingrell will join the company as a product specialist. Sue Cresswell also is joining the company’s marketing communications office.
The Will Rogers Institute will give its annual prize for Outstanding Contributions to Lung Research to Francis Collins, director of the National Human Genome Research Institute, on Dec. 6. The institute said it selected Collins for his research that led to the identification of the CFTR protein that is linked to lung diseases in some of its mutations.
Ralph Snyderman has been awarded the 2007 Leadership in Personalized Medicine Award from the Personalized Medicine Coalition. Snyderman is chancellor emeritus at Duke University and founder and chairman of Proventys. Snyderman has been a Howard Hughes Medical Institute Investigator, a Duke University researcher, and he was senior VP at Genentech.